Approval per use implanted neurostimulator
Abstract
Methods and apparatus for delivering therapy from an implanted neurostimulator to a patient are provided. One feature is an external controller that acts as a gateway for therapy. The external controller can be a handheld controller that communicates wirelessly with the implanted neurostimulator. In some embodiments, the controller communicates with a database to determine a therapy approval status of the neurostimulator. Therapy can be approved by a physician prescription, or by prepayment, for example. In some embodiments, the neurostimulator is deactivated when no approved therapies remain.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of delivering therapy to a patient, comprising:
implanting a neurostimulator on a sphenopalatine ganglion of the patient, wherein the neurostimulator is configured to: check with an external controller a therapy approval status of the implanted neurostimulator on a database; and deliver therapy to the patient if the therapy approval status of the implanted neurostimulator is approved.
2 . The method of claim 1 wherein therapy is not delivered to the patient if the therapy approval status of the implanted neurostimulator is not approved.
3 . The method of claim 2 wherein the therapy approval status is not approved if the database indicates that the implanted neurostimulator is deactivated.
4 . The method of claim 2 wherein the therapy approval status is not approved if the database indicates payment is past due.
5 . The method of claim 1 wherein the database is stored at a location separate from the external controller.
6 . The method of claim 1 wherein the external controller is an external handheld controller.
7 . The method of claim 1 wherein the external controller contains a list of deactivated and not approved neurostimulators, the method further comprising updating the list of deactivated and not approved neurostimulators.
8 . A method of approving therapy in a patient, comprising:
implanting a medical device in the patient;
approving a set number of approved therapies to be delivered from the medical device to the patient; and
deactivating the medical device when no approved therapies remain.
9 . The method of claim 8 wherein the approving step further comprises approving a set number of therapies to be delivered from the medical device to the patient with a physician prescription.
10 . The method of claim 8 wherein the approving step further comprises approving a set number of therapies to be delivered from the medical device to the patient with payment by the patient.
11 . The method of claim 8 further comprising providing the patient with a handheld controller that is configured to check a therapy approval status of the medical device.
12 . The method of claim 11 wherein the handheld controller is configured to direct the medical device to deliver therapy to the patient.
13 . The method of claim 8 further comprising re-activating the medical device by approving an additional number of therapies to be delivered from the medical device to the patient.
14 . The method of claim 8 further comprising storing a therapy approval status of the medical device on a database.
15 . The method of claim 14 wherein the controller is configured to access the database to determine the therapy approval status of the medical device.
16 . The method of claim 8 wherein the medical device is a neurostimulator.
17 . A system for delivering therapy to a patient, comprising:
an implantable neurostimulator configured to deliver therapy to the patient; a database containing a count of approval therapies of the implantable neurostimulator; and an external controller in communication with the database and the implantable neurostimulator, the external controller configured to direct the implantable neurostimulator to deliver therapy to the patient if the therapy approval status of the implantable neurostimulator is approved.
18 . The system of claim 17 wherein the implantable neurostimulator is sized and configured to be implanted on or near a sphenopalatine ganglion.
19 . The system of claim 17 wherein the external controller is a handheld controller.
20 . The system of claim 17 wherein the external controller is configured to update and store a list of the count of remaining approval therapies of the implantable neurostimulator.
21 . The system of claim 17 wherein the external controller is in wireless communication with the implantable neurostimulator and the database.
22 . The system of claim 17 wherein the therapy is electrical stimulation.
23 . The system of claim 17 wherein the external controller is configured to deactivate the implantable stimulator if no approved therapies remain.
24 . The system of claim 17 wherein the database is stored remotely from the implantable neurostimulator and the external controller.
25 . The system of claim 8 wherein the set number of approved therapies comprises a pre-determined number of approved therapies.
26 . The system of claim 17 , wherein the controller is configured to direct the database to deduct an approved therapy from the count of approved therapies when therapy is delivered to the patient.
27 . A method of delivering therapy to a patient, comprising:
implanting a neurostimulator in the patient; and providing the patient with a controller, wherein the controller is configured to: check on a database a count of approved therapies of the neurostimulator;
if the count of approved therapies is greater than zero, deliver therapy from the implanted neurostimulator to the patient; and
deduct an approved therapy from the count of approved therapies on the database.Join the waitlist — get patent alerts
Track US2015374998A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.